| Page 2 | Kisaco Research
 
Edge AI Summit 2020
18-20 Nov 2020
VIRTUAL SUMMIT | PDT Timezone
A 2020 report by Frost & Sullivan stated that 90% of industrial enterprises will be utilising edge computing by 2022. The value of the data that can be gleaned from intelligence ‘in the field’ is clear, but the current limitations of low power, on-device compute, data management and processing across the edge computing landscape continue to pose multiple engineering challenges. We’re thrilled to announce the agenda for the 3rd annual Edge AI Summit, which was the first ever dedicated summit focused on deploying machine learning on devices, and on the network infrastructure that supports the intelligent IoT. This year is all about Edge AI case studies! From ultra-low-power microwatt applications at the ‘sensor edge’, to larger milliwatt examples at the ‘device edge’ up to the non-power constrained ‘server-network edge’; we’ll be gathering a global audience (virtually!) to explore the most innovative real-world use cases of hardware and software facilitating AI at the Edge with examples from Uber AI, Google, Bosch, Magic Leap, Rakuten and many more…
 
Animal Health, Nutrition and Technology Innovation Europe 2022
21-23 Feb 2022
London, UK
Now in its 7th year, Animal Health, Nutrition and Technology Innovation Europe is the sector’s premier Innovation Summit showcasing the most exciting investment opportunities globally and connecting businesses with investors and strategic corporate partners. Our mission is to engage all key participants in the value chain so we can address the full scope of how animal health impacts pet owners, veterinarians, and farmers today.Following overwhelming feedback from the market, we have significantly expanded our programme this year with new focused content on nutrition and technology, alongside our production and companion animal health content. We will be running 4 separate innovation showcases in production animal health, companion animal health, nutrition, and technology.Our new programme will address the full extent of this ever-evolving market. We are excited to provide an innovation platform that is bigger than ever and to continue to play a critical role in shaping the future of the animal health industry by presenting the most exciting innovations in prediction, prevention, and cure.Book now to come and see for yourself!

How do companies forecast when competitors will enter the market and what role does external counsel play in shaping that view? This session explores how brand and biosimilar teams, alongside their advisors, assess patent strength, injunction likelihood, settlement dynamics and litigation risk to inform launch timing and competitive positioning.

Author:

Martina Hufnal

Principal
Fish & Richardson

Martina Hufnal

Principal
Fish & Richardson

Author:

Phil Caramanica

SVP Intellectual Property
Oculis

Phil Caramanica

SVP Intellectual Property
Oculis
 

Antje-Katrin Weigelt

SVP, General Counsel & Head of Governmental Affairs Europe
Teva

Antje-Katrin Weigelt

SVP, General Counsel & Head of Governmental Affairs Europe
Teva

Antje-Katrin Weigelt

SVP, General Counsel & Head of Governmental Affairs Europe
Teva
 

Michelle Brody

Head of Intellectual Property
International Federation of Accountants

Michelle Brody

Head of Intellectual Property
International Federation of Accountants

Michelle Brody

Head of Intellectual Property
International Federation of Accountants
 

Whitney Reichel

Principal
Fish & Richardson

Whitney Reichel

Principal
Fish & Richardson

Whitney Reichel

Principal
Fish & Richardson
 

John Kolakowski

Head of IP Policy & Advocacy
Nokia

John Kolakowski

Head of IP Policy & Advocacy
Nokia

John Kolakowski

Head of IP Policy & Advocacy
Nokia
 

Scott Allen

VP Legal & Regulatory Analysis
IPD Analytics

Scott Allen

VP Legal & Regulatory Analysis
IPD Analytics

Scott Allen

VP Legal & Regulatory Analysis
IPD Analytics
 

Charles Haisch

Executive VP Legal & Regulatory Analysis
IPD Analytics

Charles Haisch

Executive VP Legal & Regulatory Analysis
IPD Analytics

Charles Haisch

Executive VP Legal & Regulatory Analysis
IPD Analytics